Results 171 to 180 of about 408,546 (351)

Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1203-1216, April 2025.
The 366 patients diagnosed with transthyretin amyloidosis cardiomyopathy (ATTR‐CM) were analyzed regarding their clinical characteristics in the first year after approval of tafamidis 61 mg for ATTR‐CM in Germany. Nearly two‐thirds of the patients were in an advanced disease stage and 64% met the key criteria of the “Transthyretin Amyloidosis ...
Richard J. Nies   +23 more
wiley   +1 more source

The effect of coronary calcifications on interpretation of non-invasive investigations for coronary artery disease in patients with typical chest pain [PDF]

open access: yes, 2019
Coronary artery disease (CAD) is the most common cause of mortality. Invasive coronary angiography remains the gold standard for the diagnosis of patients with stable CAD and acute coronary syndromes (ACS).
Ben Grid, T.
core  

Systemic inflammation is higher in peripheral artery disease than in stable coronary artery disease.

open access: yes, 2015
OBJECTIVE The knowledge on the level of systemic inflammation in peripheral artery disease (PAD) is less well established than that in coronary artery disease (CAD).
Saely, Christoph H   +6 more
core   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

Association of High Agatston Coronary Artery Calcium Score with Critical Coronary Artery Disease: A Cross-Sectional Study from Rawalpindi, Pakistan

open access: yesLife and Science
Objective: To determine the association and pattern of critical coronary artery disease in patients with high calcium scores. Study Design: Analytical cross-sectional study.
Shaheer Farhan   +4 more
doaj   +1 more source

Awareness about Coronary Artery Disease (CAD) among Relatives of CAD Patients

open access: yesNational Journal of Community Medicine, 2017
Background: The decision to modify the cardiovascular risk factors remains with the individuals and in order to modify their lifestyle, the individual should be aware and able to perceive them as ‘risk factors’. This study was conducted to determine the level of awareness among relatives of patients diagnosed to have CAD Methodology: Cross-sectional ...
Sanjeeth Peter   +4 more
openaire   +1 more source

The Role of Layer-Specific Strain Echocardiography in The Diagnosis of Severe Coronary Artery Disease [PDF]

open access: yes
Aim: Several imaging techniques are in use for diagnosis and risk assessment in patients with suspected stable coronary artery disease (S-CAD). Measurement of global longitudinal strain (GLS) by two-dimensional speckle tracking (2D-STM) is a more ...
Hanefi Yekta GÜRLERTOP   +3 more
core   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger   +15 more
wiley   +1 more source

Serum levels of Asprosin in patients diagnosed with coronary artery disease (CAD): a case-control study. [PDF]

open access: yesLipids Health Dis, 2021
Moradi N   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy